{"id":9205,"date":"2026-05-19T15:25:41","date_gmt":"2026-05-19T15:25:41","guid":{"rendered":"https:\/\/www.centogene.com\/?page_id=9205"},"modified":"2026-08-26T08:57:32","modified_gmt":"2026-08-26T08:57:32","slug":"inversores","status":"publish","type":"page","link":"https:\/\/www.centogene.com\/es\/about-us\/investors\/","title":{"rendered":"Inversores"},"content":{"rendered":"<section class=\"bloque-banner-titulo-page  estilo-bgimage-dark\" id=\"\">\r\n    \r\n    <div class=\"image-wrapper\">\r\n\r\n      <!-- include mp4 video on a loop -->\r\n              <img decoding=\"async\" class=\"\" src=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/02\/centogene-get-in-touch-contact-us-header-01.jpg-1500x675.webp\" alt=\"centogene-get-in-touch-contact-us-header-01.jpg\" \/>\r\n          <\/div>\r\n    <div class=\"container content-wrapper\">\r\n      <div class=\"row justify-content-start align-items-center\">\r\n\r\n\r\n        <div class=\"col-12 col-lg-6 animation fadeTop align-self-center\">\r\n                  <h1>Crown LiquidationCo NV presenta las cuentas de liquidaci\u00f3n y el plan de distribuci\u00f3n.<\/h1>\r\n                                      <\/div>\r\n\r\n      <\/div>\r\n    <\/div>\r\n\r\n<\/section>\r\n<div class=\"breadcrumbs\">\r\n    <div class=\"container\">\r\n      <div class=\"row\">\r\n        <div class=\"col-12\">\r\n          <ul id=\"breadcrumbs\" class=\"breadcrumbs\"><li><a href=\"https:\/\/www.centogene.com\/es\/\">Inicio<\/a><\/li><\/ul>        <\/div>\r\n      <\/div>\r\n    <\/div>\r\n<\/div>\r\n\r\n\r\n\n\n\r\n    \r\n\r\n<section class=\"bloque-contenedor    transparente-my\"   id=\"\">\r\n    <div class=\"container\">\r\n        <div class=\"\"> \r\n                                \r\n\r\n                <div class=\"acf-innerblocks-container\">\n\n<p class=\"wp-block-paragraph\"><strong>Crown LiquidationCo NV en liquidaci\u00f3n<\/strong> (anteriormente Centogene NV) (el \u201c<strong>Compa\u00f1\u00eda<\/strong>\u201d) anuncia que las Cuentas de Liquidaci\u00f3n y el Plan de Distribuci\u00f3n (el \u201c<strong>Plan de liquidaci\u00f3n<\/strong>\u201d) han sido finalizados y presentados en el Registro Mercantil holand\u00e9s (Kamer van Koophandel) el 7 de agosto de 2026, presentaci\u00f3n que fue anunciada de conformidad con la ley holandesa el 8 de agosto de 2026.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">El liquidador continuar\u00e1 con las actividades de liquidaci\u00f3n restantes, tal como se describe en el Plan de Liquidaci\u00f3n.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Una vez finalizadas las actividades de liquidaci\u00f3n restantes, el liquidador tiene la intenci\u00f3n de proceder con una distribuci\u00f3n final de los fondos restantes de la liquidaci\u00f3n (si los hubiere) (la \u201cSegunda Distribuci\u00f3n\u201d) seg\u00fan lo previsto en el Plan de Liquidaci\u00f3n.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">La Compa\u00f1\u00eda proporcionar\u00e1 una actualizaci\u00f3n adicional en el sitio web para inversionistas con respecto a la Segunda Distribuci\u00f3n (si la hubiera), incluyendo la fecha de registro y la fecha de pago aplicables, una vez que se determinen.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/08\/Crown-LiquidationCo-N.V.-Liquidation-Accounts-Final.docx.pdf\" data-type=\"link\" data-id=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/08\/Crown-LiquidationCo-N.V.-Liquidation-Accounts-Final.docx.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Descargar el plan de liquidaci\u00f3n<\/a><\/p>\n\n\n\n<h2 class=\"wp-block-heading mt-5 has-medium-font-size\"><strong><strong>Descargo de responsabilidad<\/strong><\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Se recomienda a los inversores que lean detenidamente y en su totalidad los documentos que se hicieron p\u00fablicos en relaci\u00f3n con la Junta General Extraordinaria celebrada el 4 de diciembre de 2024 y el formulario 6-k presentado el 13 de noviembre de 2024, ya que contienen informaci\u00f3n importante sobre la Compa\u00f1\u00eda, su liquidaci\u00f3n y asuntos relacionados.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Este anuncio no constituye una oferta ni una solicitud de oferta para comprar o suscribir valores de la Compa\u00f1\u00eda. Este anuncio no debe ser divulgado, publicado ni distribuido, total o parcialmente, directa o indirectamente, en ninguna jurisdicci\u00f3n donde dicha divulgaci\u00f3n, publicaci\u00f3n o distribuci\u00f3n sea ilegal.<\/p>\n\n\n\n<h2 class=\"wp-block-heading mt-5 has-medium-font-size\"><strong><strong><strong>Declaraciones prospectivas<\/strong><\/strong><\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Este anuncio contiene \u201cdeclaraciones prospectivas\u201d seg\u00fan lo estipulado en las leyes federales de valores de EE. UU. Las declaraciones aqu\u00ed contenidas que no sean claramente hist\u00f3ricas son prospectivas, y las palabras \u201canticipar\u201d, \u201ccreer\u201d, \u201ccontinuar\u201d, \u201cesperar\u201d, \u201cestimar\u201d, \u201cpretender\u201d, \u201cproyectar\u201d, \u201cplanificar\u201d, \u201cest\u00e1 dise\u00f1ado para\u201d, \u201cpotencial\u201d, \u201cpredecir\u201d, \u201cobjetivo\u201d y expresiones similares, as\u00ed como verbos en futuro o condicional como \u201cser\u00e1\u201d, \u201cser\u00eda\u201d, \u201cdeber\u00eda\u201d, \u201cpodr\u00eda\u201d, \u201cpodr\u00eda\u201d, \u201cpuede\u201d y \u201cpuede\u201d, o sus formas negativas, generalmente se utilizan para identificar declaraciones prospectivas. Las declaraciones prospectivas pueden incluir declaraciones sobre la cantidad de fondos (si los hubiere) de la Transacci\u00f3n disponibles para pagar a los accionistas de la Compa\u00f1\u00eda en una distribuci\u00f3n de liquidaci\u00f3n, los planes de la Compa\u00f1\u00eda para disolverse, liquidar y suspender sus obligaciones de presentaci\u00f3n de informes conforme a las leyes de valores de EE. UU., y cualquier supuesto subyacente a lo anterior. Estas declaraciones prospectivas implican riesgos conocidos y desconocidos, incertidumbres y otros factores importantes que pueden causar que los resultados, el desempe\u00f1o o los logros reales de la Compa\u00f1\u00eda difieran sustancialmente de los resultados, el desempe\u00f1o o los logros futuros expresados o impl\u00edcitos en dichas declaraciones. Estos riesgos e incertidumbres incluyen, entre otros: (i) el resultado de cualquier procedimiento legal relacionado con la Transacci\u00f3n, la disoluci\u00f3n y liquidaci\u00f3n de la Compa\u00f1\u00eda o sus subsidiarias, o cualquier otra circunstancia; (ii) factores econ\u00f3micos, comerciales y\/o competitivos que puedan afectar negativamente a la Compa\u00f1\u00eda; (iii) condiciones econ\u00f3micas y geopol\u00edticas adversas, as\u00ed como inestabilidad y volatilidad en los mercados financieros mundiales; (iv) posibles cambios en la legislaci\u00f3n, las regulaciones y las pol\u00edticas gubernamentales vigentes y propuestas; (v) la capacidad de la Compa\u00f1\u00eda para optimizar el uso de efectivo; y (vi) el cumplimiento continuo por parte de la Compa\u00f1\u00eda de los convenios vinculados a los instrumentos financieros. Las declaraciones prospectivas contenidas en este anuncio son v\u00e1lidas \u00fanicamente a la fecha del presente.<\/p>\n\n\n\n<h2 class=\"wp-block-heading mt-5 has-medium-font-size\"><strong>Informaci\u00f3n adicional sobre la transacci\u00f3n y la liquidaci\u00f3n<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1757097\" target=\"_blank\" rel=\"noreferrer noopener\">Archivo de la Comisi\u00f3n de Bolsa y Valores de Estados Unidos<\/a><br><a href=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/05\/Convening-notice-with-explanatory-notes-EGM-2024.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Aviso de convocatoria con notas explicativas \u2013 Junta General Extraordinaria 2024.pdf<\/a> <br><a href=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/08\/Crown-LiquidationCo-N.V.-in-liquidatie-Announces-Cessation-of-Trading-on-OTC-Market-and-Advance-Liquidation-Distribution.pdf\" data-type=\"link\" data-id=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/08\/Crown-LiquidationCo-N.V.-in-liquidatie-Announces-Cessation-of-Trading-on-OTC-Market-and-Advance-Liquidation-Distribution.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Anuncio \u2013 Crown LiquidationCo NV en liquidaci\u00f3n anuncia el cese de operaciones en el mercado extraburs\u00e1til y la distribuci\u00f3n anticipada de la liquidaci\u00f3n.pdf<\/a><\/p>\n\n\n\n<h2 class=\"wp-block-heading mt-5 has-medium-font-size\"><strong>Contacto<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"mailto:Investor.relations@centogene.com\">Investor.relations@centogene.com<\/a><\/p>\n\n<\/div>\r\n          \r\n                            \r\n        <\/div>\r\n    <\/div>\r\n<\/section>\r\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>","protected":false},"excerpt":{"rendered":"","protected":false},"author":3,"featured_media":0,"parent":2015,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"class_list":["post-9205","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Investors | CENTOGENE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.centogene.com\/es\/sobre-nosotros\/inversores\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Investors | CENTOGENE\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.centogene.com\/es\/sobre-nosotros\/inversores\/\" \/>\n<meta property=\"og:site_name\" content=\"CENTOGENE\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-26T08:57:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"740\" \/>\n\t<meta property=\"og:image:height\" content=\"416\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/about-us\\\/investors\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/about-us\\\/investors\\\/\",\"name\":\"Investors | CENTOGENE\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\"},\"datePublished\":\"2026-05-19T15:25:41+00:00\",\"dateModified\":\"2026-08-26T08:57:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/about-us\\\/investors\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/about-us\\\/investors\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/about-us\\\/investors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.centogene.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"About us\",\"item\":\"https:\\\/\\\/www.centogene.com\\\/about-us\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Investors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"name\":\"CENTOGENE\",\"description\":\"Guiding Precision Medicine\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.centogene.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\",\"name\":\"CENTOGENE\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"contentUrl\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"width\":246,\"height\":246,\"caption\":\"CENTOGENE\"},\"image\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/centogene\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UClZxtN_laC1_ZtCdxkasdPQ\",\"https:\\\/\\\/www.instagram.com\\\/_centogene_\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Inversores | CENTOGENE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.centogene.com\/es\/sobre-nosotros\/inversores\/","og_locale":"es_ES","og_type":"article","og_title":"Investors | CENTOGENE","og_url":"https:\/\/www.centogene.com\/es\/sobre-nosotros\/inversores\/","og_site_name":"CENTOGENE","article_modified_time":"2026-08-26T08:57:32+00:00","og_image":[{"width":740,"height":416,"url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp","type":"image\/webp"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.centogene.com\/about-us\/investors\/","url":"https:\/\/www.centogene.com\/about-us\/investors\/","name":"Inversores | CENTOGENE","isPartOf":{"@id":"https:\/\/www.centogene.com\/#website"},"datePublished":"2026-05-19T15:25:41+00:00","dateModified":"2026-08-26T08:57:32+00:00","breadcrumb":{"@id":"https:\/\/www.centogene.com\/about-us\/investors\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.centogene.com\/about-us\/investors\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.centogene.com\/about-us\/investors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.centogene.com\/"},{"@type":"ListItem","position":2,"name":"About us","item":"https:\/\/www.centogene.com\/about-us\/"},{"@type":"ListItem","position":3,"name":"Investors"}]},{"@type":"WebSite","@id":"https:\/\/www.centogene.com\/#website","url":"https:\/\/www.centogene.com\/","name":"CENTOGENE","description":"Impulsar la medicina de precisi\u00f3n","publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.centogene.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.centogene.com\/#organization","name":"CENTOGENE","url":"https:\/\/www.centogene.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","contentUrl":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","width":246,"height":246,"caption":"CENTOGENE"},"image":{"@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/centogene","https:\/\/www.youtube.com\/channel\/UClZxtN_laC1_ZtCdxkasdPQ","https:\/\/www.instagram.com\/_centogene_\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/pages\/9205","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/comments?post=9205"}],"version-history":[{"count":24,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/pages\/9205\/revisions"}],"predecessor-version":[{"id":10788,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/pages\/9205\/revisions\/10788"}],"up":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/pages\/2015"}],"wp:attachment":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/media?parent=9205"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}